 |
A
A Guide to Assay Development static version printer friendly pdf version
A Guide to Business & Regulatory Strategies: Companion Diagnostic Products and Individual Therapies static version printer friendly pdf version
A Guide to Evaluating and Choosing CROs static version printer friendly pdf version
A Guide to Green-Fluorescent Protein static version printer friendly pdf version
A Guide to Pharmacovigilance in the EU. static version printer friendly pdf version
A Product Director’s Guide to Promotional Mix static version printer friendly pdf version
A Survey of Current Applications of Fluorescent Proteins in Drug Discovery static version printer friendly pdf version
Achieving Market Dominance Through Reformulation: A Strategic Insight static version printer friendly pdf version
Adult ADHD - Strattera Grows Up static version printer friendly pdf version
Advances in RNAi--A Global Technology Assessment (Technical Insights) static version printer friendly pdf version
Advancing Drug Discovery Through Structure-Guided Drug Design static version printer friendly pdf version
Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery static version printer friendly pdf version
Analysis of Prostate Cancer R&D: The Complete Guide static version printer friendly pdf version
Analytical Tool: Cancer Vaccine static version printer friendly pdf version
Angiogenesis Modulators: Strategies for Drug Discovery static version printer friendly pdf version
Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression static version printer friendly pdf version
Antibacterials and Antifungals: Technologies, Trends, and Market Opportunities, Second Edition static version printer friendly pdf version
Antibiotics and Drug Resistance static version printer friendly pdf version
Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues, Revised Edition static version printer friendly pdf version
Antisense Therapy: Technical Aspects and Commercial Opportunities static version printer friendly pdf version
Antivirals: Technologies, Trends, and Market Opportunities static version printer friendly pdf version
Applications of Stem Cells in Drug Discovery static version printer friendly pdf version
Assay Development and Technologies, 2nd Edition static version printer friendly pdf version
Aurora Kinase inhibitors - The dawn of a new approach to cancer static version printer friendly pdf version
^ Top
B
Biochips in Drug Discovery in Europe static version printer friendly pdf version
Biomanufacturing Strategies: Market Drivers, Build-vs-Buy Decisions and Opportunities in Contract Relationship Management static version printer friendly pdf version
BioMed Outsourcing Report-Drug Discovery Partnerships-The Indian Biopharmaceutical Outsourcing Sector static version printer friendly pdf version
Biomed Outsourcing Report: Drug Discovery and Development Partnerships-Outsourcing and Partnering with India static version printer friendly pdf version
Biopartnering Strategies: Maximizing returns from biotechnology deal-making static version printer friendly pdf version
Biosimilars Series: Strategic Issues - Potential Remains Uncertain static version printer friendly pdf version
Building on Early Successes of Immunomodulators in the Fight Against Cancer static version printer friendly pdf version
^ Top
C
Cancer Drug Discoveries: What the Future Holds static version printer friendly pdf version
Cancer Drug Discoveries: What the Future Holds: Non-Small Cell Lung Cancer Chapter static version printer friendly pdf version
Cancer Vaccine Developments to 2013 + Cancer Vaccine Tracker static version printer friendly pdf version
Cell Therapy: Technologies, Markets, and Opportunities static version printer friendly pdf version
Chemical Genetics in Drug Discovery static version printer friendly pdf version
Clinical Trials in India static version printer friendly pdf version
Clinical Trials: Exploring Wireless Opportunities static version printer friendly pdf version
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder Chapter static version printer friendly pdf version
CNS Drug Discoveries: What the Future Holds static version printer friendly pdf version
Commercial and Pipeline Insight: Infertility - Optimizing a market bounded by social opinion and physician preference static version printer friendly pdf version
Commercial Insight: Antidiabetics - Billion Dollar Drugs, Pipeline Dreams? static version printer friendly pdf version
Commercial Insight: Upper GI Disorders - Innovation needed to overcome generic threat static version printer friendly pdf version
Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics static version printer friendly pdf version
Compensation in Research and Development - 16th edition static version printer friendly pdf version
Competition Driving Breakthroughs in Sports Medicine Market static version printer friendly pdf version
Computational Chemistry: A Tool for Feeding R&D Pipelines static version printer friendly pdf version
Concepts in Genetic Medicine static version printer friendly pdf version
Conducting Clinical Trials in Emerging Markets static version printer friendly pdf version
Contract Research Organization Market- What Pharmaceutical and Biotechnology Companies Want static version printer friendly pdf version
COPD Drug Discovery: How New Generation Therapies Seek to Target Underlying Disease static version printer friendly pdf version
COX-2 Inhibitors - Biology, Therapeutic Agents & Markets static version printer friendly pdf version
COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact static version printer friendly pdf version
CRA Training Series (7 Volume Set) (2000) static version printer friendly pdf version
CRA Training Series Vol. 1 - An Overview of Drug Development (2000) static version printer friendly pdf version
CRA Training Series Vol. 2 - Identifying and Screening Investigators (2000) static version printer friendly pdf version
CRA Training Series Vol. 3 - Conducting the Pre-Study Visit (2000) static version printer friendly pdf version
CRA Training Series Vol. 4 - Conducting the Study Initiation Visits (2000) static version printer friendly pdf version
CRA Training Series Vol. 5 - Conducting Routine Monitoring Visits (2000) static version printer friendly pdf version
CRA Training Series Vol. 6 - The CRA's Reference for Adverse Events (2000) static version printer friendly pdf version
CRA Training Series Vol. 7 - Test Your Knowledge (2000) static version printer friendly pdf version
Current Clinical Trials: Rheumatology static version printer friendly pdf version
Current Drug Development Market for Cytokines, Chemokines and Growth Factors static version printer friendly pdf version
^ Top
D
Dendritic Cells: Targets for Immunotherapy static version printer friendly pdf version
Development and Approval of Combination Products: A Regulatory Perspective static version printer friendly pdf version
Developments in Pharmaceutical Microencapsulation in the United States static version printer friendly pdf version
Diabetes Drug Discoveries: what the future holds static version printer friendly pdf version
Diabetes Mellitus – Evaluation and Management 2007 Update static version printer friendly pdf version
Disease and Therapy Review: Alzheimers Disease static version printer friendly pdf version
Disease and Therapy Review: Bipolar Disorder static version printer friendly pdf version
Disease and Therapy Review: Constipation static version printer friendly pdf version
Disease and Therapy Review: Crohns Disease static version printer friendly pdf version
Disease and Therapy Review: End Stage Renal Disease static version printer friendly pdf version
Disease and Therapy Review: High Cholesterol static version printer friendly pdf version
Disease and Therapy Review: Irritable Bowel Syndrome static version printer friendly pdf version
Disease and Therapy Review: Major Depressive Disorder static version printer friendly pdf version
Disease and Therapy Review: Migraine static version printer friendly pdf version
Disease and Therapy Review: Multiple Sclerosis static version printer friendly pdf version
Disease and Therapy Review: Neuropathic Pain static version printer friendly pdf version
Disease and Therapy Review: Rheumatoid Arthritis static version printer friendly pdf version
Disease and Therapy Review: Schizophrenia static version printer friendly pdf version
Disease and Therapy Review: Senile Dementia static version printer friendly pdf version
Disease and Therapy Review: Systemic Lupus Erythematosus static version printer friendly pdf version
Disease and Therapy Review: Urinary Incontinence static version printer friendly pdf version
Does the Treatment of Huntingtons Disease Represent a Commercial Opportunity? static version printer friendly pdf version
Drug Development Opportunities in China: Regulation, Key Players and Initiatives for Domestic and International Markets static version printer friendly pdf version
Drug Discovery for Nervous System Diseases static version printer friendly pdf version
Drug Discovery Markets in Asia Pacific static version printer friendly pdf version
Drug Discovery Outsourcing Market in India and China static version printer friendly pdf version
Drug Discovery Research: New Frontiers in the Post-Genomic Era static version printer friendly pdf version
Drug Discovery Technologies & Platforms - Speed up your preclinical research static version printer friendly pdf version
Drug Discovery Technologies - Global Strategic Business Report static version printer friendly pdf version
Drug Discovery Tools for High-Content Analysis static version printer friendly pdf version
Drug Discovery--European Advances in Genomics and Proteomics (Technical Insights) static version printer friendly pdf version
Drug Discovery: A History static version printer friendly pdf version
Drug Metabolism in Drug Design and Development static version printer friendly pdf version
Drug Repositioning Strategies: Innovative Strategies to Boost Pipeline Productivity static version printer friendly pdf version
Drug Targets from Genomics: Evolving Tools for Discovery static version printer friendly pdf version
Drug-Drug Interactions in Pharmaceutical Development static version printer friendly pdf version
Drugs of Tommorow 2002: Breast Cancer static version printer friendly pdf version
Drugs of Tommorrow 2002: Pain static version printer friendly pdf version
Drugs of Tomorrow 2000 Vaccines: A New Era of Disease Targets static version printer friendly pdf version
Drugs of Tomorrow 2000: Allergic Rhinitis - New Drug Classes, Towards Total Disease Management static version printer friendly pdf version
Drugs of Tomorrow 2000: Arthritis - Developments For a Competitive Market static version printer friendly pdf version
Drugs of Tomorrow 2000: Lung Cancer - New Partners For Old Regimens static version printer friendly pdf version
Drugs of Tomorrow 2000: Prostate Cancer - Hormonals and Beyond static version printer friendly pdf version
Drugs of Tomorrow 2001: Anticoagulants - A pipeline flowing with future blockbusters static version printer friendly pdf version
Drugs of Tomorrow 2001: Antipsychotics - New Players in an Expanding Market static version printer friendly pdf version
Drugs of Tomorrow 2001: Bacterial Infections static version printer friendly pdf version
Drugs of Tomorrow 2001: Cancer Overview static version printer friendly pdf version
Drugs of Tomorrow 2001: Depression - A Future Away From Serotonin? static version printer friendly pdf version
Drugs of Tomorrow 2001: Diabetes static version printer friendly pdf version
Drugs of Tomorrow 2001: Dyslipidemia - The Advent of Third Generation and Combination Statins static version printer friendly pdf version
Drugs of Tomorrow 2001: Hepatitis - The Succession of New Generation Therapies static version printer friendly pdf version
Drugs of Tomorrow 2001: Hypertension - The Mounting Pressures Facing New Compounds static version printer friendly pdf version
Drugs of Tomorrow 2001: Lung Cancer static version printer friendly pdf version
Drugs of Tomorrow 2001: Migraine - Impact of the Novel Triptan Class on Acute Treatment Market static version printer friendly pdf version
Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Success static version printer friendly pdf version
Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline Facing Chronic Unmet Needs static version printer friendly pdf version
Drugs of Tomorrow 2002: Arthritis static version printer friendly pdf version
Drugs of Tomorrow 2002: Colorectal Cancer static version printer friendly pdf version
Drugs of Tomorrow 2002: Depression - A pipeline driven by side effect profile static version printer friendly pdf version
Drugs of Tomorrow 2002: Reperfusion Injury - The Next Breakthrough in Clinical Cardiology static version printer friendly pdf version
Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs static version printer friendly pdf version
Drugs of Tomorrow: Cancer Overview static version printer friendly pdf version
Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovatives compliment traditional chemotherapies static version printer friendly pdf version
Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed static version printer friendly pdf version
Drugs: From Discovery to Approval static version printer friendly pdf version
Due Diligence in Life Science Transactions, 2nd Edition static version printer friendly pdf version
^ Top
E
Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi static version printer friendly pdf version
Emerging Drug Targets in Alzheimers Disease static version printer friendly pdf version
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs static version printer friendly pdf version
Emerging Pharmaceutical Markets: Growth Opportunities, Changing Healthcare Dynamics and Regulatory Trends static version printer friendly pdf version
Ethical Issues in Drug Development:A Deterrent To Fraud and other Malfeasance static version printer friendly pdf version
European Cell Based Assays Markets static version printer friendly pdf version
European Generic Drug Market Potential static version printer friendly pdf version
European Urinary Incontinence Therapeutics Markets static version printer friendly pdf version
^ Top
G
G-Protein Coupled Receptors (GPCRs): Technical Overview, Emerging Technologies, Market Trends & Opportunities, 2nd Edition static version printer friendly pdf version
Gastrointestinal Drug Discoveries: What the Future Holds static version printer friendly pdf version
Generic Series: Benchmarking Patent Expiries - Key Factors Affecting Brand Erosion At Patent Expiry static version printer friendly pdf version
Genomics Players: From Discovery to Integration- Business and Technology Assessment, 2002 static version printer friendly pdf version
Genomics: Pharmaceutical Investment, Integration and Partnerships static version printer friendly pdf version
Global Market for Plant Derived Drugs, 2005-2012 static version printer friendly pdf version
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development static version printer friendly pdf version
Glycogen synthase kinase 3 inhibitors: Proof of concept and therapeutic opportunities for the treatment of diabetes, Alzheimer's disease, stroke and bipolar disorder static version printer friendly pdf version
Gpcrs: The Targets of Today's Drugs and Tomorrow's Blockbusters static version printer friendly pdf version
^ Top
H
Hepatitis C virus (HCV) - Future HCV Drug Discovery Technologies static version printer friendly pdf version
Herg: Technology and Market Analysis static version printer friendly pdf version
High Content Screening: Science, Techniques and Applications static version printer friendly pdf version
High Density Multiplexed Assays: Obstacles and Opportunities for Bioscience Markets static version printer friendly pdf version
High-tech immunization static version printer friendly pdf version
HIV Update 2001 (2): Midyear Market Analysis and Forecasts static version printer friendly pdf version
HIV Update 2002 (3) - March static version printer friendly pdf version
How Overcoming the Challenge of Biomarker Validation Can Pay Off for Drug and Diagnostic Developers static version printer friendly pdf version
Hypoglycaemia in Clinical Diabetes, 2nd Edition static version printer friendly pdf version
^ Top
I
Iminosugars: From Synthesis to Therapeutic Applications static version printer friendly pdf version
Industry Analysis - Changing Dynamics in Worldwide Psychiatric Franchises static version printer friendly pdf version
Innovations in Cardiovascular Disease Management: Latest Surgical Procedures, Drugs and Medical Devices static version printer friendly pdf version
Investigator-Initiated Trials: Building Superior IIT Capabilities static version printer friendly pdf version
Ion Channel Assays in the Drug Discovery Process static version printer friendly pdf version
Ion Channel Drug Discovery - Therapeutic Opportunities & Technology Progress static version printer friendly pdf version
Ion Channels as Therapeutic Targets for Multiple Diseases static version printer friendly pdf version
Ion Channels: Technology Advances Driving Commercial Opportunities static version printer friendly pdf version
^ Top
K
KeywordPharma Conference Insights - Accelerating Patient Recruitment in Clinical Trials static version printer friendly pdf version
Knowledge Management Tools for Drug Discovery static version printer friendly pdf version
^ Top
L
Lead Optimization - A Reinvention of the Process static version printer friendly pdf version
Licensing in Antibacterial R&D - Filling the Gaps static version printer friendly pdf version
^ Top
M
Male and female sexual dysfunction: Blockbuster indication for multiple pharmacological targets static version printer friendly pdf version
Market Opportunities and Challenges for Antibody Arrays and Beads: A Market Research Study static version printer friendly pdf version
Mastering Phase IV Clinical Trials static version printer friendly pdf version
Maximizing R&D Productivity: Getting More Bang For Your R&D Buck static version printer friendly pdf version
Medication Reconciliation Strategies to Reduce Hospital Adverse Drug Events static version printer friendly pdf version
Medicinal Chemistry: An Introduction, 2nd Edition static version printer friendly pdf version
Medicines in Development for Brain Cancer static version printer friendly pdf version
Medicines in Development for Cervical Cancer static version printer friendly pdf version
Melanoma Therapeutics: Which Strategy Will Take Us There? static version printer friendly pdf version
Model Organisms in Drug Discovery and Development: An Industry Analysis static version printer friendly pdf version
Molecular Approaches Towards Hepatitis C virus (HCV) Therapy - The Complete Guide static version printer friendly pdf version
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development static version printer friendly pdf version
Molecular Therapeutics: 21st Century Medicine static version printer friendly pdf version
^ Top
N
Nanotechnology for Drug Discovery and Drug Design static version printer friendly pdf version
Navigating the Drug Discovery Landscape: A Strategic Overview of Pharmaceutical R&D static version printer friendly pdf version
New Drug Development: A Regulatory Overview (8th Edition) static version printer friendly pdf version
New Drug Development: Design, Methodology, and Analysis static version printer friendly pdf version
New Drug Discovery and Development static version printer friendly pdf version
New Drugs Approved in Germany, 1988-2002 static version printer friendly pdf version
New Drugs in Development for Acne static version printer friendly pdf version
New Drugs in Development for Alzheimers Disease static version printer friendly pdf version
New Drugs in Development for Alzheimers Disease Indications Addressed static version printer friendly pdf version
New Drugs in Development for Anxiety static version printer friendly pdf version
New Drugs in Development for Arrhythmia static version printer friendly pdf version
New Drugs in Development for Asthma static version printer friendly pdf version
New Drugs in Development for Atherosclerosis static version printer friendly pdf version
New Drugs in Development for Attention-Deficit/Hyperactivity Disorder static version printer friendly pdf version
New Drugs in Development for Lung Cancer New Medicines in Development static version printer friendly pdf version
New Options for Treating Neurological Disease: Stem Cell Therapy static version printer friendly pdf version
New Targets and Drug Discovery Platforms in Antifungal R&D static version printer friendly pdf version
Next Generation Drugs: Acceleration Through Innovation static version printer friendly pdf version
Next-Generation Biologics: Improving on Monoclonal Antibodies static version printer friendly pdf version
Nitric Oxide - Therapeutics, Markets and Companies static version printer friendly pdf version
Novel Targets in Drug Discovery static version printer friendly pdf version
Number of Drugs in Preclinical Testing by Year, 1995-2004 static version printer friendly pdf version
Number of Drugs in Preclinical Testing, 1995-2004 static version printer friendly pdf version
Number of New Drugs in Development in Canada by Top Therapeutic Category, 2004 static version printer friendly pdf version
Nutrition: Science and Applications with Booklet Package static version printer friendly pdf version
^ Top
O
Obesity Drug Discoveries: What the Future Holds static version printer friendly pdf version
Obesity Drug Discoveries: What The Future Holds + Obesity Tracker static version printer friendly pdf version
Obesity Drug Discovery: Success and Challenges for a New Pharmaceutical Market static version printer friendly pdf version
Obesity Therapeutics: Understanding Market Dynamics (Presentation) static version printer friendly pdf version
Opportunities for Bioinformatics in European Drug Discovery Markets static version printer friendly pdf version
Optimizing the Clinical Trial Process: Strategies to Reduce Costs and Increase Quality static version printer friendly pdf version
Outlook for the Migraine Market With Novel Approaches Limited, Triptans Dominate static version printer friendly pdf version
Outsourcing Drug Discovery to China and India static version printer friendly pdf version
Outsourcing Opportunities in India and China (Two Reports) static version printer friendly pdf version
Overcoming Challenges in Antibacterial Drug Discovery and Development static version printer friendly pdf version
^ Top
P
Pain Therapeutics: A New Era of Research Innovations and Commercial Opportunities static version | |